Proteomic analysis identifies argininosuccinate synthetase 1 and special AT-rich sequence binding protein 1 as reliable markers for the immunohistochemical distinction between WHO types A and B3 thymomas.
Felix BremmerHanibal BohnenbergerPeter FindeisenStefan WelterAlexander von Hammerstein-EquordMarc HinterthanerDenise MüllerStefan KüfferSatoru OkadaAlexander MarxPhilipp StroebelPublished in: Histopathology (2023)
Mutually exclusive epithelial expression of ASS1 in 100% of type B3 thymomas and ectopic nuclear expression of SATB1 in 92% of type A thymomas support the distinction between type A and type B3 thymomas with 94% sensitivity, 98% specificity and 96% accuracy.